Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

Completed

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- Patients with an episode of cerebral infarction (excluding cardiogenic cerebral thromboembolism) occurring at least 8 days prior to randomization and for whom the clinical course up to randomization is well-documented
- Patients with a cerebral infarct confirmed by Computed Tomography or Magnetic Resonance Image
- Body weight : > 50 kg

Exclusion Criteria

- Patients with cardiogenic cerebral thromboembolism or disease that could precipitate cardiogenic cerebral thromboembolism, such as atrial fibrillation or valvular hear disease (including valve replacement)
- Patients with Transient Ischemic Attack occuring after the last episode of cerebral infarction
- Patients with serious impairment that would hinder detection of new ischemic event
- Patients with bleeding diathesis, coagulopathy, or hemorrhagic disease
- Patients with history of intracranial hemorrhage
- Patients with diabetic retinopathy
- Hypertensive patients with a persistent increase of blood pressure.